CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia

Leukemia. 2006 Jan;20(1):149-51. doi: 10.1038/sj.leu.2404052.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cyclin-Dependent Kinase Inhibitor p15 / genetics*
  • DNA Methylation
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis*
  • Leukemia, Promyelocytic, Acute / genetics*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate

Substances

  • CDKN2B protein, human
  • Cyclin-Dependent Kinase Inhibitor p15